Study suggests single-dose psilocybin as safe and effective treatment for major depressive disorder
Credit: JAMA (2023). DOI: 10.1001/jama.2023.14530 A collaboration between 34 researchers from 18 institutions analyzed the efficacy and safety of psilocybin in patients with major depressive disorder. In an article, “Single-dose psilocybin treatment for major depressive disorder: a randomized controlled trial,” published in JAMAthe team found a rapid onset of antidepressant effects, sustained reduction in depressive … Read more